Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 12/20 | 0.73 |
| ▸ | MMP3 | P08254 | 12/20 | 0.73 |
| ▸ | CCNT1 | O60563 | 6/20 | 0.47 |
| ▸ | CDK9 | P50750 | 6/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | PTGDR | Q13258 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6588399 | 0.90 | MMP2 (0.59) | MMP2MMP3CCNT1CDK9LMNA | |
| SCHEMBL6583589 | 0.85 | MMP3 (0.79) | MMP2MMP3CCNT1CDK9LMNA | |
| SCHEMBL6586215 | 0.84 | MMP3 (1.00) | MMP2MMP3 | |
| SCHEMBL6587727 | 0.83 | MMP3 (0.76) | MMP2MMP3LMNA | |
| SCHEMBL6589722 | 0.83 | MMP3 (0.81) | MMP2MMP3CCNT1CDK9 | |
| SCHEMBL6590023 | 0.82 | MMP2 (0.77) | MMP2MMP3CCNT1CDK9 | |
| SCHEMBL6586818 | 0.82 | MMP3 (0.80) | MMP2MMP3 | |
| SCHEMBL6585982 | 0.81 | MMP3 (0.86) | MMP2MMP3LMNA | |
| SCHEMBL6584456 | 0.81 | MMP3 (1.00) | MMP2MMP3 | |
| SCHEMBL6587316 | 0.81 | MMP2 (0.73) | MMP2MMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1036062-B1 | HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE (MMP) INHIBITORS | PFIZER LTD (GB) | 2004-01-02 | — | — | EP | disclosed |
| US-6495568-B1 | TREATMENT OF TISSUE ULCERATION, WOUND REPAIR AND SKIN DISEASES | WARNER-LAMBERT COMPANY | 2002-12-17 | — | — | US | disclosed |